Germany’s new Federal Drug Commissioner, Prof Dr Hendrik Streeck (CDU), who in June had spoken solely vaguely concerning the partial legalisation of hashish, has since taken a sharper stance.
In current feedback to the press, Streeck signalled that he expects important modifications to present coverage – and these is probably not beneficial for the trade, sufferers, or customers. He argued that the Hashish Act (CanG) lacks coherence and rigour, significantly in relation to medical use.
Requires reform
Based on Streeck, the foundations on private cultivation are unrealistic. Expert growers, he famous, can harvest as much as one kilogram of hashish flowers from three crops, which he considers extreme.
In an interview with the Deutsches Ärzteblatt (German Medical Journal), he additionally welcomed Well being Minister Nina Warken’s (CDU) draft regulation to tighten telemedicine guidelines. At current, too many sufferers are acquiring hashish by on-line pharmacies, he stated, with some utilizing it recreationally. This, he argued, is mirrored within the 80% rise in medical hashish gross sales.
Opposition to hashish flowers
Streeck is especially crucial of prescribing hashish in flower type. As a result of it’s most frequently smoked, he warned that it poses well being dangers like lung harm and most cancers.
As an alternative, he advocates the usage of capsules or drops for situations similar to ache or epilepsy, and has stated hashish flowers ought to not be prescribed in any respect.

Ready for knowledge
Regardless of his criticism, Streeck pointed to the continuing analysis of the CanG, whose outcomes can be revealed in two phases – in autumn and spring. These stories will analyse developments within the illicit market, site visitors accidents, consumption developments, and instances of cannabis-induced psychosis.
READ MORE: The New Federal Authorities Medication Commissioner Stays Obscure on the Hashish Concern
SPD pushes again
Whereas the CDU favours restrictions on telemedicine, its coalition accomplice, the Social Democratic Celebration (SPD), shouldn’t be aligned. Carmen Wegge, SPD rapporteur for the Inside and Authorized Affairs Committee, acknowledged on abgeordnetenwatch.de that the occasion would ‘certainly not’ help the proposed restrictions of their present type.
In early August, Wegge emphasised that making certain ‘dependable, native, and barrier-free care’ should stay a precedence. On-line entry to hashish medicines, she stated, is significant for sufferers with power or critical sickness, in addition to for these in areas with restricted GP protection.
She additionally confirmed that the SPD helps the broader paradigm shift in drug coverage, together with pilot initiatives with licensed hashish retailers and, in the long term, full legalisation consistent with EU regulation.
Subsequent steps
Any draft regulation from the Federal Ministry of Well being would first endure session inside the ministry earlier than cupboard dialogue, and later debate within the Bundestag and its specialist committees. A number of negotiation levels stay earlier than a remaining place is reached. The SPD has made clear it’s going to search to guard affected person entry to hashish medicines whereas making certain satisfactory safeguards.
Business stakeholders, together with corporations and medical associations, are additionally voicing opposition to proscribing hashish flowers, arguing for therapeutic freedom and affected person selection. Their case can be explored additional in a forthcoming Enterprise of Hashish article.